7 results found.

Maternal Fetal Factors Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Restriction: A Longitudinal Study.

Preeclampsia Clinical Trial using Pravastatin; Placebo

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Recruiting 18 years or older.
- Pravastatin for the Prevention of Preeclampsia in High-Risk Women: A Phase I Pilot Study.
Pravastatin; Placebo

Preeclampsia Clinical Trial

Mike O'Callaghan Federal Hospital - Recruiting 18 years to 45 years.
- Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia.

Preeclampsia Clinical Trial using Lovenoxr (enoxaparin); Aspegic r (Aspirin)

Assistance Publique - H“pitaux de Paris - Recruiting 18 years or older.
- Low Molecular Weight Heparin, Enoxaparin, to Prevent Adverse Maternal and Perinatal Outcomes in Women With Previous Severe Preeclampsia at Less Than 34 Weeks' Gestation. A Prospective Randomized Trial.
Lovenoxr (enoxaparin); Aspegic r (Aspirin)

Preeclampsia Clinical Trial using Apheresis using Liposorber LA-15 System

Massachusetts General Hospital - Recruiting 18 years to 45 years.
- Phase 1b Proof-of-Concept Study of Apheresis to Reduce Soluble Fms-like Tyrosine Kinase-1 (sFlt-1) in Pregnant Women With Preeclampsia Using a Dextran Sulfate Adsorption (DSA) Column (LIPOSORBERr LA-15 System).
Apheresis using Liposorber LA-15 System

Preeclampsia Clinical Trial

Oslo University Hospital - Recruiting 18 years to 50 years.
- Hemodynamic Measurements in Women With Serious Preeclampsia.